(Reuters) -Eli Lilly hit $1 trillion in market value on Friday, making it the first drugmaker to enter the exclusive club dominated by tech giants and underscoring its rise as a weight-loss powerhouse.
Here are some reactions to Lilly joining the trillion dollar club:
EVAN SEIGERMAN, ANALYST AT BMO CAPITAL MARKETS
"The current valuation points to investor confidence in the longer-term durability of the company's metabolic health franchise. It also suggests that investors prefer Lilly over Novo in the obesity arms race. Taking a step back, we're also seeing money rotate into the sector as investors may be worried about an AI bubble."
HANK SMITH, DIRECTOR & HEAD OF INVESTMENT STRATEGY AT LILLY SHAREHOLDER HAVERFORD TRUST
"Investors have historically liked secure earnings growth and (Eli Lilly) is the only large cap pharma that has that kind of earnings profile."
(Reporting by Siddhi Mahatole and Shashwat Chauhan in Bengaluru; Editing by Leroy Leo)
LATEST POSTS
- 1
vote in favor of Your #1 kind of climate - 2The most effective method to Look at Medical caretaker Compensations Across Various Clinics
- 3The most effective method to Examine a Cellular breakdown in the lungs Finding with Family
- 4Exploring School Life: Self-awareness and Illustrations
- 5Staggering Spots to Stargaze All over the Planet
- Reality TV star Spencer Pratt, who lost his home in Palisades Fire, is running for mayor of Los Angeles
- Fundamental Home Machines for Improved Solace in Summer
- Vote in favor of the wide open action that revives your brain and soul!
- Florence's Uffizi Gallery moves treasures to safety after cyberattack
- This is Countdown, CNN’s newsletter covering NASA’s first time sending humans to deep space in over 50 years
- Instructions to Pick the Right Dental Embed Trained professional: An Exhaustive Aide
- Katz, IDF: We assassinated IRGC intelligence chief Majid Khademi
- What Yogurt Types Do You Know
- 5 Most Expected Film Delivery
